<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2022.891495</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Therapeutic Potential of Photosynthetic Microorganisms for Visceral Leishmaniasis: An Immunological Analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Vaitkevicius-Ant&#xe3;o</surname>
<given-names>Victor</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1095052"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moreira-Silva</surname>
<given-names>Jady</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1838043"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reino</surname>
<given-names>Isabelle Barreto da Silva Moreira</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Melo</surname>
<given-names>Maria Gabriella Nunes de</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1838034"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silva-J&#xfa;nior</surname>
<given-names>Jos&#xe9; No&#xe9; da</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Andrade</surname>
<given-names>Alexsandra Fraz&#xe3;o de</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ara&#xfa;jo</surname>
<given-names>Paulo S&#xe9;rgio Ramos de</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bezerra</surname>
<given-names>Raquel Pedrosa</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1834104"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marques</surname>
<given-names>Daniela de Ara&#xfa;jo Viana</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ferreira</surname>
<given-names>Silvana</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pessoa-e-Silva</surname>
<given-names>R&#xf4;mulo</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/489588"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lorena</surname>
<given-names>Virginia Maria Barros de</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1189326"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Paiva-Cavalcanti</surname>
<given-names>Milena de</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/127108"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Microbiology, Aggeu Magalh&#xe3;es Institute, Fiocruz Pernambuco</institution>, <addr-line>Recife</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Research Support Center, Federal Rural University of Pernambuco</institution>, <addr-line>Recife</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of Biological Sciences, University of Pernambuco</institution>, <addr-line>Recife</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Central Public Health Laboratory of Pernambuco, Endemics Laboratory</institution>, <addr-line>Recife</addr-line>, <country>Brazil</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Immunology, Aggeu Magalh&#xe3;es Institute, Fiocruz Pernambuco</institution>, <addr-line>Recife</addr-line>, <country>Brazil</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Abhay Satoskar, The Ohio State University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: F&#xe1;tima Ribeiro-Dias, Universidade Federal de Goi&#xe1;s, Brazil; Ranadhir Dey, United States Food and Drug Administration, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Milena de Paiva-Cavalcanti, <email xlink:href="mailto:milena.cavalcanti@fiocruz.br">milena.cavalcanti@fiocruz.br</email></p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Parasite Immunology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>06</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>891495</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>03</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>05</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Vaitkevicius-Ant&#xe3;o, Moreira-Silva, Reino, Melo, Silva-J&#xfa;nior, Andrade, Ara&#xfa;jo, Bezerra, Marques, Ferreira, Pessoa-e-Silva, Lorena and Paiva-Cavalcanti</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Vaitkevicius-Ant&#xe3;o, Moreira-Silva, Reino, Melo, Silva-J&#xfa;nior, Andrade, Ara&#xfa;jo, Bezerra, Marques, Ferreira, Pessoa-e-Silva, Lorena and Paiva-Cavalcanti</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>New therapeutic strategies for visceral leishmaniasis (VL) have been studied, and the development of an immunotherapeutic agent that modulates the host&#x2019;s immune response is necessary. The aim of this study was to evaluate <italic>in vitro</italic> the bioactive extracts of photosynthetic microorganisms (PMs) for their leishmanicidal/leishmanistatic and immunomodulatory potentials. Bioactive extracts from PMs (<italic>Arthrospira platensis</italic> and <italic>Dunaliella tertiolecta</italic>) were obtained by sonication. Reference drugs, miltefosine (MTF) and N-methylglucamine antimoniate (Sb<sup>V</sup>), were also evaluated. The selectivity index (SI) of treatments was determined by assays of inhibitory concentration (IC<sub>50</sub>) in <italic>Leishmania infantum</italic> cells and cytotoxic concentrations (CC<sub>50</sub>) in human peripheral blood mononuclear cells by the MTT method. The immune response was evaluated in healthy human cells by the production of cytokines and nitric oxide (NO) and the gene expression of <italic>Tbx21</italic>, <italic>GATA3</italic>, <italic>RORc</italic>, and <italic>FOXP3</italic>, using four concentrations (CC<sub>50</sub>, &#xbd; CC<sub>50</sub>, &#xbc; CC<sub>50</sub>, and IC<sub>50</sub>) for <italic>in-vitro</italic> stimulation. Based on the data obtained, we observed that the extracts of <italic>D. tertiolecta</italic> (SI = 4.7) and <italic>A. platensis</italic> (SI = 3.8) presented better results when compared to Sb<sup>V</sup> (SI = 2.1). When analyzing the immune response results, we identified that the extracts of PMs stimulated the production of cytokines of the Th1 profile more than the reference drugs. The extracts also demonstrated the ability to stimulate NO synthesis. Regarding gene expression, in all concentrations of <italic>A. platensis</italic> extracts, we found a balance between the Th1/Th2 profile, with the average expression of the <italic>Tbx21</italic> gene more than the <italic>GATA3</italic> in the highest concentration (CC<sub>50</sub>). Regarding the extract of <italic>D. tertiolecta</italic>, we can observe that, in the lowest concentrations, a balance between all the genes was present, with the average expression of the <italic>GATA3</italic> gene being lower than the others. The best result was found in the &#xbd; CC<sub>50</sub> concentration, stimulating a balanced positive expression between the Th1&#xd7;Th17&#xd7;Treg profiles, with a negative expression of <italic>GATA3</italic>. Thus, PM extracts showed promising results, presenting low toxicity, leishmanicidal/leishmanistatic activity, and induction of the immune response, which could be potential therapeutic candidates for VL.</p>
</abstract>
<kwd-group>
<kwd>cyanobacteria</kwd>
<kwd>
<italic>Leishmania infantum</italic>
</kwd>
<kwd>microalgae</kwd>
<kwd>immunomodulation</kwd>
<kwd>therapy</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="42"/>
<page-count count="11"/>
<word-count count="5629"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>The lack of therapeutic alternatives is one of the greatest obstacles to control visceral leishmaniasis (VL). In the treatment of VL, the drug of first choice for humans is N-methylglucamine antimoniate (Glucantime<sup>&#xae;</sup>, Sanofi-Aventis, France), and for dogs, it is miltefosine (Milteforan&#x2122;, Virbac, France). However, these drugs are highly toxic to the host and have been presenting treatment failures and reports of parasite resistance (<xref ref-type="bibr" rid="B1">1</xref>).</p>
<p>The host&#x2019;s immune response against the parasite must change, at least in part, to achieve therapeutic success against VL; in this context, the use of immunomodulatory drugs that can reverse the host&#x2019;s immune profile, stimulating a profile of resistance against the parasite, is important to complement conventional treatment, helping in the patient&#x2019;s clinical improvement (<xref ref-type="bibr" rid="B2">2</xref>). To investigate the protective immune response stimulated by a therapeutic candidate, understanding the immunological mechanisms in leishmaniasis is essential, as these parasites have developed, throughout evolution, several evasion mechanisms to survive the host&#x2019;s immune system (<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>The host&#x2019;s cellular immune response is mediated by CD4<sup>+</sup> T lymphocytes which, in a simplified way, can present two types of profiles: resistance (Th1) and susceptibility (Th2). The Th1 profile produces cytokines such as interferon-gamma (IFN-&#x3b3;), tumor necrosis factor (TNF), and interleukin 2 (IL-2), which are associated with the control of infection by macrophages, the production of nitric oxide (NO), and the consequent destruction of intracellular parasites. On the other hand, the Th2 profile is characterized by the synthesis of cytokines such as interleukin 4 (IL-4), interleukin 10 (IL-10), and tumor growth factor-beta (TGF-&#x3b2;), favoring the onset of the disease and its symptoms, with inhibition of synthesized NO by activated macrophages, providing the survival of the parasites (<xref ref-type="bibr" rid="B4">4</xref>&#x2013;<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>Other cell subtypes such as regulatory T cells (Treg) and Th17 may also play a significant role in susceptibility and resistance against leishmaniasis (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). However, despite the Th1/Th2 (resistance/susceptibility) paradigm being a simplified model, several studies have demonstrated its foundation (<xref ref-type="bibr" rid="B10">10</xref>&#x2013;<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>Based on this knowledge about the immunological profile of VL, studies that aim to investigate new molecules with potential against visceral leishmaniasis can be performed. Microorganisms, such as photosynthetic microorganisms, are promising candidates for therapeutic investigations since they have a variety of metabolites with different biological activities that have not been fully studied yet (<xref ref-type="bibr" rid="B13">13</xref>&#x2013;<xref ref-type="bibr" rid="B15">15</xref>). Studies with Chlorophyta extracts have demonstrated anti-inflammatory and antiparasitic activities (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>), in addition to an immunomodulatory potential (<xref ref-type="bibr" rid="B18">18</xref>). Thus, with a broader vision for the control of leishmaniasis, this study aimed to evaluate the <italic>in-vitro</italic> therapeutic potential for VL of the bioactive extracts of two species of photosynthetic microorganisms, <italic>Arthrospira platensis</italic> and <italic>Dunaliella tertiolecta</italic>, in human cells.</p>
</sec>
<sec id="s2">
<title>Material and Methods</title>
<sec id="s2_1">
<title>Obtaining Bioactive Extracts of Photosynthetic Microorganisms</title>
<p>Two photosynthetic microorganisms (PMs), the cyanobacterium <italic>A. platensis</italic> (Utex, 1926) and the microalgae <italic>D. tertiolecta</italic> (Utex, 1644), were obtained from the University of Texas culture collection. <italic>Arthrospira platensis</italic> was cultivated in a 250-ml Erlenmeyer flask containing 100 ml of Schl&#xf6;sser medium (<xref ref-type="bibr" rid="B19">19</xref>) in an orbital shaker at 75 &#xb1; 5 rpm, while <italic>D. tertiolecta</italic> was cultivated in a 1-L Erlenmeyer flask containing 400 ml of f/2 medium (<xref ref-type="bibr" rid="B20">20</xref>), under constant aeration. Both cultivations used an initial biomass concentration of 50 mg/L, temperature of 27&#xb0;C &#xb1; 1&#xb0;C, and continuous light intensity of 52 &#xb1; 4 &#x3bc;mol photons m<sup>&#x2212;2</sup>&#xa0;s<sup>&#x2212;1</sup> (<xref ref-type="bibr" rid="B21">21</xref>).</p>
<p>After reaching the stationary growth phase, the cultures were centrifuged at 430&#xd7;<italic>g</italic> for 10 min (Hermle Labortechnik 326 HK, Wehingen, Germany), lyophilized (SP Scientific BenchTop Pro, Warminster, USA), resuspended (100 mg ml<sup>&#x2212;1</sup>) in 0.1 M of Tris&#x2013;HCl buffer pH 7.0, and sonicated at 20 pulses in an ice bath with intervals of 1 min between each pulse (<xref ref-type="bibr" rid="B22">22</xref>). The homogenate was centrifuged at 10,000&#xd7;<italic>g</italic> for 5 min at 4&#xb0;C, and the supernatant filtered at 0.22 &#xb5;m was denominated bioactive extract and used for further analysis. Protein concentration was determined by the method of Smith et&#xa0;al. (<xref ref-type="bibr" rid="B23">23</xref>) using the Micro BCA Protein Assay Kit (Pierce).</p>
</sec>
<sec id="s2_2">
<title>Cultivation of <italic>Leishmania infantum</italic>
</title>
<p>The promastigotes of <italic>L. infantum</italic> (strain MHOM/BR/1972/BH46) were culture-expanded in Schneider medium (Sigma-Aldrich) pH 7.2, containing 10% of fetal bovine serum (FBS&#x2014;Vitrocell<sup>&#xae;</sup>, Brazil) and 1% of antibiotic (penicillin 200 U/ml). The peaks were performed between the third and fourth day of cultivation and incubated in a biochemical oxygen demand greenhouse (BOD) at a temperature of &#xb1;26&#xb0;C, to be used in the leishmanicidal effect tests.</p>
<p>To obtain the antigenic fractions, the parasitic mass was subjected to rapid freezing (&#x2212;197&#xb0;C) in liquid nitrogen, followed by thawing (40&#xb0;C). Soon after, the cell suspension was subjected to the ultrasonication process (60 s/40 W), three times, and centrifuged at 10,000&#xd7;<italic>g</italic> for 20 min at 4&#xb0;C. The resulting supernatant was a soluble antigen fraction (<italic>L. infantum</italic> soluble antigen: LSA). Proteins were quantified by the Bradford method (<xref ref-type="bibr" rid="B24">24</xref>), and the fraction was stored at &#x2212;80&#xb0;C. LSA was used in the cell culture assays.</p>
</sec>
<sec id="s2_3">
<title>Sample Collection and Peripheral Blood Mononuclear Cell Isolation</title>
<p>Whole blood was collected from healthy human individuals by venipuncture using heparin tubes (18 ml) to perform the separation of peripheral blood mononuclear cells (PBMCs). Phosphate-buffered saline (PBS) (pH 7.2) was added to heparinized blood in a proportion of 1:2. This mixture was added to Ficoll-Hypaque at a ratio of 1:3 (Ficoll-Hypaque:blood) to obtain the ring of PBMCs after centrifugation at 900&#xd7;<italic>g</italic> for 30 min without brake. Cells were washed twice in PBS and then resuspended in 1 ml of RPMI 1640 medium supplemented with 10% of FBS and 1% of penicillin/streptomycin (200 U/ml). Cells were counted in a Neubauer chamber using Trypan Blue dye. The cell value obtained was adjusted to a concentration of 1 &#xd7; 10<sup>6</sup> cells/ml by adding RPMI 1640 medium supplemented with 10% of FBS, to be used in the assays.</p>
</sec>
<sec id="s2_4">
<title>Determination of the Selectivity Index</title>
<p>The selectivity index (SI) was calculated as the ratio between the 50% cytotoxic concentration (CC<sub>50</sub>) in human cells and the 50% inhibitory concentration (IC<sub>50</sub>) in parasite cultures. All cells were treated with bioactive extracts of photosynthetic microorganisms and reference drugs (N-methylglucamine antimoniate and miltefosine).</p>
<p>PBMCs from healthy humans were cultivated in 96-well plates and treated with different stimuli to evaluate the CC<sub>50</sub>. Cell treatment (containing 1 &#xd7; 10<sup>6</sup> cells/ml) was performed in triplicate for each stimulus, incubated for 24 h, using concentrations of 62.5 to 1,000 &#xb5;g/ml of bioactive extracts of PMs (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>). After the culture time, the supernatant was discarded and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] was added at a concentration of 1 mg/ml, solubilized in RPMI 1640 medium without phenol red, and incubated in an oven at 37&#xb0;C for 3 h. Subsequently, the formazan crystals formed were solubilized with dimethylsulfoxide (DMSO) and then read in a spectrophotometer at 540 nm (<xref ref-type="bibr" rid="B27">27</xref>).</p>
<p>Cells of <italic>L. infantum</italic> in the promastigote form were cultivated for the evaluation of the IC<sub>50</sub> of the PM bioactive extracts. Cell treatment was performed in triplicate for each stimulus, incubated for 48 h in a 96-well plate containing 1 &#xd7; 10<sup>6</sup> cells/ml (<xref ref-type="bibr" rid="B28">28</xref>). After the culture time, the cells were counted and evaluated for their morphology under a light microscope. For natural extracts, protein concentrations of 15.63 to 500 &#xb5;g/ml were used (<xref ref-type="bibr" rid="B29">29</xref>). For N-methylglucamine antimoniate and miltefosine, the concentration curves were 15.63 to 250 &#xb5;g/ml and 0.1 to 4 &#xb5;g/ml, respectively (<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B31">31</xref>). Three independent experiments were carried out in triplicates.</p>
</sec>
<sec id="s2_5">
<title>Immune Response Analysis</title>
<p>Whole blood was collected from healthy humans to obtain the PBMCs. PBMC cultures were performed in 48-well polystyrene plates, containing 5 &#xd7; 10<sup>5</sup> cells/well, and stimulated with the mitogen phytohemagglutinin (PHA) (10 &#xb5;g/ml) (positive control of the culture), the soluble antigen of <italic>L. infantum</italic> (LSA) (25 &#xb5;g/ml) (<xref ref-type="bibr" rid="B32">32</xref>), N-methylglucamine antimoniate, miltefosine, and natural extracts. The concentration values&#x2014;CC<sub>50</sub>, &#xbd; CC<sub>50</sub>, &#xbc; CC<sub>50</sub>, and IC<sub>50</sub>&#x2014;of the reference drugs and natural extracts were determined. Unstimulated wells served as a negative control.</p>
<sec id="s2_5_1">
<title>Evaluation of Cytokine Production</title>
<p>From the supernatants of human PBMC cultures, cytokine secretion (IFN-&#x3b3;, TNF, IL-2, IL-4, IL-6, IL-10) was measured using the BD&#x2122; CBA Human Th1/Th2 Cytokine kit (Becton Dickinson, United States). The reading was performed in the FACSCalibur flow cytometry equipment (Becton Dickinson, United States), according to the manufacturer&#x2019;s guidelines. The results were analyzed using the FCAP Array 3.0 software (Becton Dickinson, United States), being normalized with the results obtained by non-stimulated cells. So, if the value is presented as negative, it means that there is an inhibition of cytokine production since the detected value is lower than that presented by the non-stimulated PBMCs.</p>
</sec>
<sec id="s2_5_2">
<title>Evaluation of Nitric Oxide Production</title>
<p>Quantification of NO levels was indirectly performed by measuring nitrite in culture supernatants, by the Griess reaction, according to Resende et&#xa0;al. (<xref ref-type="bibr" rid="B7">7</xref>). The stimuli (LSA, N-methylglucamine antimoniate, miltefosine, and natural extracts) were compared with the negative control (PBMCs without stimulus).</p>
</sec>
<sec id="s2_5_3">
<title>Evaluation of mRNA Expression</title>
<p>The evaluation of the relative expression of messenger RNA (mRNA) of specific transcription factors (Tbx21, GATA3, RORc, and FOXP3) from the culture of healthy human PBMCs was performed. After the cultivation time, RNA extraction was performed with the TRIzol<sup>&#xae;</sup> (Invitrogen, Thermo Fisher Scientific, United States) method, measuring the mRNA concentration in a spectrophotometer and storing it at &#x2212;80&#xb0;C.</p>
<p>After obtaining the mRNA, reverse transcription to complementary DNA (cDNA) was performed using the commercial TaqMan Reverse Transcription reagent kit (Applied Biosystems, Life Technology, United States). The cycling conditions followed the manufacturer&#x2019;s guidelines (25&#xb0;C for 10 min, 37&#xb0;C for 30 min, 95&#xb0;C for 5 min, 4&#xb0;C until removal).</p>
<p>A real-time qPCR was performed from the cDNA (TaqMan<sup>&#xae;</sup> System, Applied Biosystems, Life Technology, United States) using the QuantStudio 5 sequence detection system and the TaqMan<sup>&#xae;</sup> Gene Expression PCR Master Mix kit (Applied Biosystems, Life Technology, United States) for the main regulatory genes <italic>T-bet</italic>/<italic>Tbx21</italic> (ID: Hs00894392_m1), <italic>GATA3</italic> (ID: Hs00231122_m1), <italic>RORc</italic> (ID: Hs01076112_m1), and <italic>FOXP3</italic> (ID: Hs01085834_m1). As an endogenous control of the reaction, <italic>GAPDH</italic> was used (ID: Hs02786624_g1). All samples were analyzed in duplicate and expressed as the mean &#xb1; standard error of the mean, using the PHA mitogen as a calibrator to calculate the relative quantification value.</p>
</sec>
</sec>
<sec id="s2_6">
<title>Data Analysis</title>
<p>Probit regression analyses were performed using the IBM SPSS Statistic 25 software program in order to determine the values of CC<sub>50</sub> and IC<sub>50</sub>. Also, comparative analyses were performed using descriptive statistics techniques with absolute and percentage distributions. The Kolmogorov&#x2013;Smirnov normality test was used, and according to the analysis, Student&#x2019;s <italic>t</italic>-test (parametric) or the Mann&#x2013;Whitney test (non-parametric) was performed for comparisons between two categories, or one-way analysis of variance (ANOVA) with Tukey post-test (parametric) or Kruskal&#x2013;Wallis with Dunn&#x2019;s post-test (non-parametric) was performed for comparisons between more than two categories. Correlation analyses were also performed using Pearson&#x2019;s test (parametric) and Spearman&#x2019;s test (non-parametric). All tests were performed using the GraphPad Prism 5 program (GraphPad Software Inc. 2007, San Diego, CA, USA), and a <italic>p</italic>-value &lt;0.05 was considered significant.</p>
</sec>
<sec id="s2_7">
<title>Ethical Considerations</title>
<p>Before the collection, human individuals included in the study were invited to participate and sign an informed consent form, authorizing the use of the collected material for scientific purposes. This study is part of the project &#x201c;Immunology applied to the development of new control strategies for leishmaniasis&#x201d; which has the approval of the Research Ethics Committee: CAAE 89972718.8.0000.5190 No. 4,077,060 (Fiocruz/PE).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Determination of the Selectivity Index</title>
<p>Assays for the determination of CC<sub>50</sub> and IC<sub>50</sub> were performed, and it was observed that the extract of <italic>A. platensis</italic> had the lowest toxicity for human PBMCs, presenting a CC<sub>50</sub> of approximately 1,000 &#xb5;g/ml. In turn, <italic>D. tertiolecta</italic> presented higher toxicity to <italic>L. infantum</italic>, with a lower IC<sub>50</sub>.</p>
<p>By analyzing the reference drugs Sb<sup>V</sup> and MTF, we observed that MTF was more toxic to <italic>L. infantum</italic> cells as well as to the host cells. Despite the high toxicity, the MTF was over 100 times more selective than other treatments (SI = 129.6). On the other hand, Sb<sup>V</sup> had the lowest SI (2.11), demonstrating that the extracts of <italic>A. platensis</italic> and <italic>D. tertiolecta</italic> were more selective for the parasite (SI = 3.8 and 4.7, respectively) than this reference drug, which is currently used for the treatment of VL in Brazil. <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref> shows the CC<sub>50</sub> and IC<sub>50</sub> values as well as the SI.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Leishmanicidal activity (IC<sub>50</sub>) in promastigotes and cytotoxic effect (CC<sub>50</sub>) in human cells treated with bioactive extracts of photosynthetic microorganisms and reference drugs.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" rowspan="2" align="left">Treatment</th>
<th valign="top" align="center">IC<sub>50</sub>
</th>
<th valign="top" align="center">CC<sub>50</sub>
</th>
<th valign="top" align="center">SI</th>
</tr>
<tr>
<th valign="top" align="center">
<italic>L. infantum</italic> (&#xb5;g/ml)</th>
<th valign="top" align="center">Human PBMCs (&#xb5;g/ml)</th>
<th valign="top" align="center">CC<sub>50</sub>/IC<sub>50</sub>
</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">
<italic>A. platensis</italic>
</td>
<td valign="top" align="center">259.20</td>
<td valign="top" align="center">986.11</td>
<td valign="top" align="center">3.80</td>
</tr>
<tr>
<td valign="top" align="left">
<italic>D. tertiolecta</italic>
</td>
<td valign="top" align="center">53.75</td>
<td valign="top" align="center">252.55</td>
<td valign="top" align="center">4.70</td>
</tr>
<tr>
<td valign="top" align="left">Sb<sup>V</sup>
</td>
<td valign="top" align="center">195.15</td>
<td valign="top" align="center">412.46</td>
<td valign="top" align="center">2.11</td>
</tr>
<tr>
<td valign="top" align="left">Miltefosine</td>
<td valign="top" align="center">1.23</td>
<td valign="top" align="center">159.49</td>
<td valign="top" align="center">129.6</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>SI, selectivity index; PBMCs, peripheral blood mononuclear cells; Sb<sup>V</sup>, N-methylglucamine antimoniate.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_2">
<title>Cytokine Quantification</title>
<p>For the extracts, we observed that both <italic>A. platensis</italic> and <italic>D. tertiolecta</italic> induced the production of cytokines of the Th1 profile by PBMCs, at all concentrations evaluated, demonstrating a positive stimulus against VL (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). We emphasized IL-10, which gradually decreased its production as the concentration of the extracts increased, with statistically significant differences between the concentrations of the <italic>A. platensis</italic> (<italic>p</italic>-value = 0.031) and <italic>D. tertiolecta</italic> (<italic>p</italic>-value = 0.007) extracts.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Dosage of cytokines produced by cells stimulated with bioactive extracts of photosynthetic microorganisms. <bold>(A, E)</bold> CC<sub>50</sub> value; <bold>(B, F)</bold> half of the CC<sub>50</sub> value; <bold>(C, G)</bold> one quarter of the CC<sub>50</sub> value; <bold>(D, H)</bold> IC<sub>50</sub> value. LSA, <italic>Leishmania infantum</italic> soluble antigen; Ap, <italic>Arthrospira platensis</italic>; Dt, <italic>Dunaliella tertiolecta</italic>. *Statistical difference = <italic>p</italic>-value &lt; 0.05. Limit of detection (IFN-&#x3b3;: 7.1; TNF: 2.8; IL-10: 2.8). The cytokine produced for each treatment was subtracted by the cytokine produced from non-stimulated cells.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-891495-g001.tif"/>
</fig>
<p>Comparing the results obtained from the extract of <italic>A. platensis</italic> with LSA, we observed the presence of a Th1-protective response for all concentrations, with IFN-&#x3b3; stimulation higher than that observed with the natural infection mimicked by LSA, with a statistically significant difference for the IC<sub>50</sub> concentration (<italic>p</italic>-value = 0.032) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). For all concentrations (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A&#x2013;D</bold>
</xref>), the <italic>A. platensis</italic> extract did not stimulate TNF production that was superior to LSA, with statistically significant differences, but it stimulated the production of this cytokine more than the cells without stimulation. Regarding the extract of <italic>D. tertiolecta</italic>, compared to LSA, we detected that, for all concentrations, a Th1-protective response was found, with the mean of TNF stimulation higher than that observed with LSA (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1E&#x2013;H</bold>
</xref>). Furthermore, at the concentration of CC<sub>50</sub>, a lower stimulus for IL-10 production (<italic>p</italic>-value = 0.002) and for IFN-&#x3b3; (<italic>p</italic>-value = 0.008) was found than LSA (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>). <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref> shows the mean values of cytokine production (in pg/ml) after cell stimulation with the four concentrations of each extract.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Mean (&#xb1; SEM) concentrations (in pg/ml) of cytokines produced by cells stimulated with the extracts of <italic>Arthrospira platensis</italic> and <italic>Dunaliella tertiolecta</italic>.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Cytokine</th>
<th valign="top" align="center">CC<sub>50</sub>
</th>
<th valign="top" align="center">&#xbd; CC<sub>50</sub>
</th>
<th valign="top" align="center">&#xbc; CC<sub>50</sub>
</th>
<th valign="top" align="center">IC<sub>50</sub>
</th>
<th valign="top" align="center">
<italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" colspan="6" align="left">
<italic>A. platensis</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">IFN-&#x3b3;</td>
<td valign="top" align="char" char="&#xb1;">13.63 &#xb1; 5.77</td>
<td valign="top" align="char" char="&#xb1;">11.90 &#xb1; 2.45</td>
<td valign="top" align="char" char="&#xb1;">12.54 &#xb1; 2.79</td>
<td valign="top" align="char" char="&#xb1;">14.78 &#xb1; 4.18</td>
<td valign="top" align="center">0.92</td>
</tr>
<tr>
<td valign="top" align="left">TNF</td>
<td valign="top" align="char" char="&#xb1;">40.71 &#xb1; 7.44</td>
<td valign="top" align="char" char="&#xb1;">41.27 &#xb1; 6.77</td>
<td valign="top" align="char" char="&#xb1;">61.19 &#xb1; 11.25</td>
<td valign="top" align="char" char="&#xb1;">64.18 &#xb1; 6.18</td>
<td valign="top" align="center">0.63</td>
</tr>
<tr>
<td valign="top" align="left">IL-10</td>
<td valign="top" align="char" char="&#xb1;">48.77 &#xb1; 30.91</td>
<td valign="top" align="char" char="&#xb1;">137.2 &#xb1; 42.81</td>
<td valign="top" align="char" char="&#xb1;">229.9 &#xb1; 55.75</td>
<td valign="top" align="char" char="&#xb1;">255.7 &#xb1; 58.40</td>
<td valign="top" align="center">0.031*</td>
</tr>
<tr>
<td valign="top" align="left">IL-4</td>
<td valign="top" align="char" char="&#xb1;">0.21 &#xb1; 0.09</td>
<td valign="top" align="char" char="&#xb1;">0.33 &#xb1; 0.14</td>
<td valign="top" align="char" char="&#xb1;">&#x2212;0.03 &#xb1; 0.09</td>
<td valign="top" align="char" char="&#xb1;">0.18 &#xb1; 0.13</td>
<td valign="top" align="center">0.21</td>
</tr>
<tr>
<td valign="top" align="left">IL-2</td>
<td valign="top" align="char" char="&#xb1;">&#x2212;1.03 &#xb1; 0.24</td>
<td valign="top" align="char" char="&#xb1;">&#x2212;0.46 &#xb1; 0.56</td>
<td valign="top" align="char" char="&#xb1;">&#x2212;1.20 &#xb1; 0.31</td>
<td valign="top" align="char" char="&#xb1;">&#x2212;0.72 &#xb1; 0.13</td>
<td valign="top" align="center">0.48</td>
</tr>
<tr>
<td valign="top" colspan="6" align="left">
<italic>D. tertiolecta</italic>
</td>
</tr>
<tr>
<td valign="top" align="left">IFN-&#x3b3;</td>
<td valign="top" align="char" char="&#xb1;">&#x2212;3.502 &#xb1; 2.93</td>
<td valign="top" align="char" char="&#xb1;">0.674 &#xb1; 2.75</td>
<td valign="top" align="char" char="&#xb1;">4.542 &#xb1; 3.01</td>
<td valign="top" align="char" char="&#xb1;">5.504 &#xb1; 4.58</td>
<td valign="top" align="center">0.20</td>
</tr>
<tr>
<td valign="top" align="left">TNF</td>
<td valign="top" align="char" char="&#xb1;">225.0 &#xb1; 59.88</td>
<td valign="top" align="char" char="&#xb1;">143.3 &#xb1; 38.05</td>
<td valign="top" align="char" char="&#xb1;">160.2 &#xb1; 31.57</td>
<td valign="top" align="char" char="&#xb1;">146.0 &#xb1; 28.23</td>
<td valign="top" align="center">0.48</td>
</tr>
<tr>
<td valign="top" align="left">IL-10</td>
<td valign="top" align="char" char="&#xb1;">&#x2212;21.48 &#xb1; 29.12</td>
<td valign="top" align="char" char="&#xb1;">37.85 &#xb1; 36.79</td>
<td valign="top" align="char" char="&#xb1;">175.1 &#xb1; 34.85</td>
<td valign="top" align="char" char="&#xb1;">146.3 &#xb1; 38.75</td>
<td valign="top" align="center">0.007*</td>
</tr>
<tr>
<td valign="top" align="left">IL-4</td>
<td valign="top" align="center">&#x2212;0.038</td>
<td valign="top" align="center">0.20</td>
<td valign="top" align="center">&#x2212;0.148</td>
<td valign="top" align="center">0.142</td>
<td valign="top" align="center">0.51</td>
</tr>
<tr>
<td valign="top" align="left">IL-2</td>
<td valign="top" align="center">&#x2212;0.942</td>
<td valign="top" align="center">&#x2212;0.43</td>
<td valign="top" align="center">&#x2212;0.704</td>
<td valign="top" align="center">&#x2212;1.074</td>
<td valign="top" align="center">0.43</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Limit of detection (IFN-&#x3b3;: 7.1 pg/ml; TNF: 2.8 pg/ml; IL-10: 2.8 pg/ml; IL-4: 2.6 pg/ml; IL-2: 2.6 pg/ml). Five independent experiments were performed with different individuals. The cytokine produced for each treatment was subtracted by the cytokine produced from non-stimulated cells.</p>
</fn>
<fn>
<p>CC<sub>50</sub>, 50% cytotoxic concentration; IC<sub>50</sub>, 50% inhibitory concentration.</p>
</fn>
<fn>
<p>*Statistical difference = p-value &lt;0.05 compared among the concentrations.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>When analyzing the correlation of cytokines and the extracts, we observed that between TNF and IL-4, in the CC<sub>50</sub> and &#xbd; CC<sub>50</sub> concentrations of the <italic>A. platensis</italic> extract, there were a very strong and significant negative correlation (<italic>r</italic> = &#x2212;0.92; <italic>p</italic>-value = 0.02) and a significant positive correlation (<italic>r</italic> = &#x2212;0.97; <italic>p</italic>-value = 0.01), respectively. For the extract of <italic>D. tertiolecta</italic>, we observed very strong but not significant correlations. <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref> shows the correlation data of cytokines induced by the extracts.</p>
<p>Regarding the reference drugs, all concentrations of Sb<sup>V</sup>, except IC<sub>50</sub>, showed an immunological suppression, with only IL-10 being stimulated. As for MTF, all concentrations, except IC<sub>50</sub>, showed immunological suppression, with stimulation of only TNF at the &#xbc; CC<sub>50</sub> concentration. <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref> shows the mean values of cytokine production stimulated by the concentrations of each drug. Regarding the correlation between cytokines, for Sb<sup>V</sup>, there were very strong but not significant correlations. For MTF, we observed very strong and significant negative correlations between IL-4 and IL-2 in the CC<sub>50</sub> concentration (<italic>r</italic> = 0.90; <italic>p</italic>-value = 0.03) and between TNF and IL-10 in the IC<sub>50</sub> concentration (<italic>r</italic> = 0.91; <italic>p</italic>-value = 0.01). <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2</bold>
</xref> shows the correlation data of cytokines induced by the reference drugs.</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Means of concentrations (in pg/ml) of cytokines produced by cells stimulated with the reference drugs.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Cytokine</th>
<th valign="top" align="center">CC<sub>50</sub>
</th>
<th valign="top" align="center">&#xbd; CC<sub>50</sub>
</th>
<th valign="top" align="center">&#xbc; CC<sub>50</sub>
</th>
<th valign="top" align="center">IC<sub>50</sub>
</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" colspan="5" align="left">N-methylglucamine antimoniate</td>
</tr>
<tr>
<td valign="top" align="left">IFN-&#x3b3;</td>
<td valign="top" align="center">&#x2212;2.853</td>
<td valign="top" align="center">&#x2212;3.743</td>
<td valign="top" align="center">&#x2212;1.335</td>
<td valign="top" align="center">2.000</td>
</tr>
<tr>
<td valign="top" align="left">TNF</td>
<td valign="top" align="center">&#x2212;2.603</td>
<td valign="top" align="center">&#x2212;0.300</td>
<td valign="top" align="center">&#x2212;0.418</td>
<td valign="top" align="center">0.900</td>
</tr>
<tr>
<td valign="top" align="left">IL-10</td>
<td valign="top" align="center">8.112</td>
<td valign="top" align="center">2.213</td>
<td valign="top" align="center">4.268</td>
<td valign="top" align="center">11.82</td>
</tr>
<tr>
<td valign="top" align="left">IL-4</td>
<td valign="top" align="center">&#x2212;0.398</td>
<td valign="top" align="center">&#x2212;0.403</td>
<td valign="top" align="center">&#x2212;0.288</td>
<td valign="top" align="center">0.298</td>
</tr>
<tr>
<td valign="top" align="left">IL-2</td>
<td valign="top" align="center">&#x2212;1.138</td>
<td valign="top" align="center">&#x2212;1.395</td>
<td valign="top" align="center">&#x2212;0.720</td>
<td valign="top" align="center">&#x2212;0.640</td>
</tr>
<tr>
<td valign="top" colspan="5" align="left">Miltefosine</td>
</tr>
<tr>
<td valign="top" align="left">IFN-&#x3b3;</td>
<td valign="top" align="center">&#x2212;4.660</td>
<td valign="top" align="center">&#x2212;4.635</td>
<td valign="top" align="center">&#x2212;3.998</td>
<td valign="top" align="center">1.538</td>
</tr>
<tr>
<td valign="top" align="left">TNF</td>
<td valign="top" align="center">&#x2212;8.105</td>
<td valign="top" align="center">&#x2212;4.945</td>
<td valign="top" align="center">0.635</td>
<td valign="top" align="center">&#x2212;2.138</td>
</tr>
<tr>
<td valign="top" align="left">IL-10</td>
<td valign="top" align="center">&#x2212;35.08</td>
<td valign="top" align="center">&#x2212;35.16</td>
<td valign="top" align="center">&#x2212;34.54</td>
<td valign="top" align="center">0.128</td>
</tr>
<tr>
<td valign="top" align="left">IL-4</td>
<td valign="top" align="center">&#x2212;0.263</td>
<td valign="top" align="center">&#x2212;0.39</td>
<td valign="top" align="center">&#x2212;0.185</td>
<td valign="top" align="center">&#x2212;0.273</td>
</tr>
<tr>
<td valign="top" align="left">IL-2</td>
<td valign="top" align="center">&#x2212;1.670</td>
<td valign="top" align="center">&#x2212;1.748</td>
<td valign="top" align="center">&#x2212;1.508</td>
<td valign="top" align="center">&#x2212;1.138</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Limit of detection (IFN-&#x3b3;: 7.1 pg/ml; TNF: 2.8 pg/ml; IL-10: 2.8 pg/ml; IL-4: 2.6 pg/ml; IL-2: 2.6 pg/ml). Five independent experiments were performed with different individuals. The cytokine produced for each treatment was subtracted by the cytokine produced from non-stimulated cells.</p>
</fn>
<fn>
<p>CC<sub>50</sub>, 50% cytotoxic concentration; IC<sub>50</sub>, 50% inhibitory concentration.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_3">
<title>Quantification of Nitric Oxide</title>
<p>For the extracts, we observed a slightly higher NO production when compared to cells without stimulus and stimulated with LSA (which demonstrated a reduction in NO production, when compared to cells without stimulus). We also identified that the nitrite dosage was directly proportional to the stimulus concentration (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>). Statistically significant differences were observed between the highest concentration (CC<sub>50</sub>) of each extract compared with the LSA (<italic>A. platensis</italic>: <italic>p</italic>-value = 0.017; <italic>D. tertiolecta</italic>: <italic>p</italic>-value = 0.005).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Measurement of nitrite after cell stimulation with bioactive extracts of photosynthetic microorganisms. LSA, soluble antigen of Leishmania infantum (25 &#xb5;g/ml). *Statistical difference = p-value &lt; 0.05. Limit of detection (0.055). The nitrite measured for each treatment was subtracted by the nitrite measured from non-stimulated cells.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-891495-g002.tif"/>
</fig>
<p>In turn, the reference drugs also obtained a measurement of nitrite that was a little higher than the cells without stimulation and stimulated with LSA, but no proportionality between dosage and concentration was detected. For Sb<sup>V</sup>, a statistically significant difference was found between the concentrations of &#xbd; CC<sub>50</sub> (<italic>p</italic>-value = 0.028) and &#xbc; CC<sub>50</sub> (<italic>p</italic>-value = 0.023) with the LSA, pointing out a higher NO induction of these concentrations compared to the antigen. Moreover, for MTF, a statistically significant difference was also found between the CC<sub>50</sub> and LSA (<italic>p</italic>-value = 0.041).</p>
</sec>
<sec id="s3_4">
<title>Gene Expression</title>
<p>From the stimulated cells, messenger RNA was extracted and reverse-transcribed to cDNA for quantification, targeting the genes <italic>Tbx21</italic>, <italic>GATA3</italic>, <italic>RORc</italic>, and <italic>FOXP3</italic>, which are related to the induction of T-cell differentiation for the Th1, Th2, Th17, and Treg profiles, respectively.</p>
<p>When analyzing the results of gene expression stimulated with natural extracts (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>), we observed that in all concentrations of <italic>A. platensis</italic> extract, a balance between the Th1/Th2 profile was present, with the average expression of the <italic>Tbx21</italic> gene being higher than that of <italic>GATA3</italic> at the highest stimulus concentration, with no statistical difference observed, similar to the results of gene expression stimulated with LSA. Notably, the <italic>FOXP3</italic> gene at the highest concentration showed a negative expression (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>), and the <italic>RORc</italic> gene varied from concentration to concentration, showing a greater expression at the &#xbc; CC<sub>50</sub> concentration (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>
<bold>;</bold> <xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Relative quantification (RQ Log10) of gene expression of specific transcriptional factors after cell stimulation with bioactive extracts of photosynthetic microorganisms. <bold>(A, E)</bold> CC<sub>50</sub> value; <bold>(B, F)</bold> half of the CC<sub>50</sub> value; <bold>(C, G)</bold> one quarter of the CC<sub>50</sub> value; <bold>(D, H)</bold> IC<sub>50</sub> value. LSA, <italic>Leishmania infantum</italic> soluble antigen (25 &#xb5;g/ml); Ap, <italic>Arthrospira platensis</italic>; Dt, <italic>Dunaliella tertiolecta</italic>. The calibrator used was phytohemagglutinin (PHA). *Statistical difference = <italic>p</italic>-value &lt; 0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-891495-g003.tif"/>
</fig>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Relative quantification (RQ Log10) of gene expression of specific transcriptional factors after cell stimulation with bioactive extracts of photosynthetic microorganisms.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Gene</th>
<th valign="top" align="center">CC<sub>50</sub>
</th>
<th valign="top" align="center">&#xbd; CC<sub>50</sub>
</th>
<th valign="top" align="center">&#xbc; CC<sub>50</sub>
</th>
<th valign="top" align="center">IC<sub>50</sub>
</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" colspan="5" align="left">
<italic>Arthrospira platensis</italic>
</td>
</tr>
<tr>
<td valign="top" align="left"><italic>Tbx21</italic>
</td>
<td valign="top" align="center">0.49</td>
<td valign="top" align="center">0.36</td>
<td valign="top" align="center">0.57</td>
<td valign="top" align="center">0.67</td>
</tr>
<tr>
<td valign="top" align="left"><italic>GATA3</italic>
</td>
<td valign="top" align="center">0.30</td>
<td valign="top" align="center">0.47</td>
<td valign="top" align="center">0.64</td>
<td valign="top" align="center">0.62</td>
</tr>
<tr>
<td valign="top" align="left"><italic>RORc</italic>
</td>
<td valign="top" align="center">0.05</td>
<td valign="top" align="center">&#x2212;0.14</td>
<td valign="top" align="center">0.38</td>
<td valign="top" align="center">0.05</td>
</tr>
<tr>
<td valign="top" align="left"><italic>FOXP3</italic>
</td>
<td valign="top" align="center">&#x2212;0.04</td>
<td valign="top" align="center">0.29</td>
<td valign="top" align="center">0.21</td>
<td valign="top" align="center">0.51</td>
</tr>
<tr>
<td valign="top" colspan="5" align="left">
<italic>Dunaliella tertiolecta</italic>
</td>
</tr>
<tr>
<td valign="top" align="left"><italic>Tbx21</italic>
</td>
<td valign="top" align="center">&#x2212;0.02</td>
<td valign="top" align="center">0.69</td>
<td valign="top" align="center">0.73</td>
<td valign="top" align="center">0.71</td>
</tr>
<tr>
<td valign="top" align="left"><italic>GATA3</italic>
</td>
<td valign="top" align="center">&#x2212;0.41</td>
<td valign="top" align="center">&#x2212;0.20</td>
<td valign="top" align="center">0.49</td>
<td valign="top" align="center">0.24</td>
</tr>
<tr>
<td valign="top" align="left"><italic>RORc</italic>
</td>
<td valign="top" align="center">0.19</td>
<td valign="top" align="center">0.65</td>
<td valign="top" align="center">0.69</td>
<td valign="top" align="center">0.64</td>
</tr>
<tr>
<td valign="top" align="left"><italic>FOXP3</italic>
</td>
<td valign="top" align="center">&#x2212;0.05</td>
<td valign="top" align="center">0.29</td>
<td valign="top" align="center">0.79</td>
<td valign="top" align="center">0.88</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>RQ Log10 = 2<sup>&#x2212;&#x394;&#x394;Ct</sup>. The calibrator used was phytohemagglutinin (PHA).</p>
</fn>
<fn>
<p>CC<sub>50</sub>, 50% cytotoxic concentration; IC<sub>50</sub>, 50% inhibitory concentration.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Regarding the extract of <italic>D. tertiolecta</italic>, we observed that at the lowest concentrations (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3G, H</bold>
</xref>), there was a balance between all the inducing genes, with the average expression of the <italic>GATA3</italic> gene being lower than the others. As shown by the results, the &#xbd; CC<sub>50</sub> concentration (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>) stimulated a balanced and positive expression between the Th1&#xd7;Th17&#xd7;Treg profiles, with a negative expression of <italic>GATA3</italic>, inducing the Th2 profile, and a statistically significant difference was observed when compared to LSA (<italic>p</italic>-value = 0.009). At the highest concentration, there was only a positive expression of the <italic>RORc</italic> gene (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). Analyzing the correlation between genes, for <italic>A. platensis</italic>, a very strong positive correlation was observed between <italic>Tbx21</italic> and <italic>RORc</italic> at the &#xbd; CC<sub>50</sub> concentration (<italic>r</italic> = 0.95; <italic>p</italic>-value = 0.047). Regarding the correlation analysis of the extract of <italic>D. tertiolecta</italic>, at the concentrations tested, no significant correlations were detected. <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;3</bold>
</xref> shows the correlation data of gene expression induced by the extracts.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>When searching for new therapeutic strategies, low toxicity to host cells is one of the important factors to be considered in identifying a potent therapeutic candidate (<xref ref-type="bibr" rid="B33">33</xref>). In this study, <italic>A. platensis</italic> extract demonstrated a higher CC<sub>50</sub> value than the active principles of the drugs currently used for the treatment of VL and CVL (Glucantime<sup>&#xae;</sup> and Milteforan&#x2122;, respectively).</p>
<p>As alternative candidates for the development of therapeutics, photosynthetic marine organisms have been studied for their anti-<italic>Leishmania</italic> capacity; however, studies evaluating phytoplankton for their effect against <italic>Leishmania</italic> sp. are very scarce, being only reported by Pereira et&#xa0;al. (<xref ref-type="bibr" rid="B17">17</xref>), which evaluated the leishmanicidal activity of methanol extracts of four species of Chlorophyta, from three different genera (<italic>Nannochloris</italic>, <italic>Picochlorum</italic>, and <italic>Desmochloris</italic>). Therefore, further studies on the leishmanicidal effects of photosynthetic marine microorganisms are necessary, demonstrating the significance of this study. Thus, when comparing our results with those found by Pereira et&#xa0;al. (<xref ref-type="bibr" rid="B17">17</xref>), assessing the extracts of Chlorophyta species, we noted that the extracts of <italic>D. tertiolecta</italic> presented a lower IC<sub>50</sub> value, that is, a greater leishmanicidal/leishmanistatic activity, since the concentration of <italic>Nannochloris</italic> sp. (250 &#xb5;g/ml) that was used reduced the viability of <italic>L. infantum</italic> by 38%.</p>
<p>When observing the leishmanicidal/leishmanistatic activity of the natural extracts in this study, we noted that the IC<sub>50</sub> values were lower when compared to the values of some organic plant extracts evaluated by Bouyahya et&#xa0;al. (<xref ref-type="bibr" rid="B34">34</xref>), with IC<sub>50</sub> values ranging between 82.39 and 500 &#xb5;g/ml, which were more toxic for <italic>L. infantum</italic>. Making a new comparison, this time with meroditerpenoid isolates from a brown macroalgae (<italic>Cystoseira baccata</italic>) evaluated by Sousa et&#xa0;al. (<xref ref-type="bibr" rid="B35">35</xref>), we observed in our study that the SI of the extract of <italic>D. tertiolecta</italic> was higher, since the SI obtained by the Sousa et&#xa0;al. was less than 10, using murine peritoneal macrophages, demonstrating that the extracts studied here may have promising potential.</p>
<p>Although the extracts from both <italic>A. platensis</italic> and <italic>D. tertiolecta</italic> studied here do not present an SI greater than 10 in assays with human cells, we do not exclude the immunomodulatory potential of these extracts. As observed in the study by Costa-Silva et&#xa0;al. (<xref ref-type="bibr" rid="B36">36</xref>), isolates from natural products, despite presenting an SI less than 10, had immunomodulatory activity against <italic>L. infantum</italic>, reducing the production of Th2 profile cytokines, in addition to stimulating chemokines associated with a decrease in the parasite load.</p>
<p>When evaluating the immune response induced by bioactive extracts of photosynthetic microorganisms of the species <italic>A. platensis</italic> and <italic>D. tertiolecta</italic>, a positive immune stimulus of the cells was observed. Different concentrations were studied, but all maintained the same general pattern of the immune response, a balance between pro-inflammatory and anti-inflammatory cytokines, with some concentrations having a slightly greater emphasis on the Th1 profile cytokines.</p>
<p>
<italic>Arthrospira platensis</italic> is a cyanobacterium with some biological activities that have been known for some years by the scientific community. The immunomodulatory potential of this microorganism has been indicated in the literature, stimulating the production of IFN-&#x3b3; and TNF and reducing the production of IL-10, both in mice (<xref ref-type="bibr" rid="B37">37</xref>) and in human PBMCs (<xref ref-type="bibr" rid="B38">38</xref>). In addition to the extract, phycocyanin (photosynthetic pigment), a protein isolated from <italic>A. platensis</italic>, studied by Sheikh et&#xa0;al. (<xref ref-type="bibr" rid="B39">39</xref>) when they performed PBMC treatment, also demonstrated an increase in IFN-&#x3b3;. These findings corroborate our results, since we observed a greater production of IFN-&#x3b3; and TNF compared to cells without stimulus, with special emphasis on IFN-&#x3b3; that showed a greater synthesis compared to LSA, with a statistical difference in the lowest concentration.</p>
<p>In addition to stimulating the production of Th1 cytokines, the <italic>A. platensis</italic> extract also induced the synthesis of the leishmanicidal factor, strengthening the hypothesis that this extract is a good candidate for treating VL. The expression of specific transcriptional factor genes showed a balance, but with no statistically significant differences, strengthening the hypothesis that this extract stimulates the modulation of the immune response by expressing the <italic>Tbx21</italic> gene, responsible for activating the differentiation of Th1 lymphocytes.</p>
<p>Although <italic>D. tertiolecta</italic> is a halophilic microalgae widely used in food and feed supplementation, there are few studies reporting the immunological activity of this species. Based on these few studies about immune response, the immunological activity of this species was observed <italic>in vitro</italic> in PBMCs from sheep, making it possible to identify the ability of phytosterols from this species to stimulate an immune response. Among these phytosterols, 7-dehydroporiferasterol and ergosterol induced the production of the cytokine IL-10 and the reduction of IL-6 and TNF, demonstrating an anti-inflammatory role (<xref ref-type="bibr" rid="B40">40</xref>). Likewise, in the study by Caroprese et&#xa0;al. (<xref ref-type="bibr" rid="B41">41</xref>), an increase in IL-10 synthesis was observed, with a reduction in pro-inflammatory cytokines. In addition, a dose-dependent IL-10 was identified, which was also found in our study; however, in our results, we observed that with increasing concentration, IL-10 decreased.</p>
<p>In our study, the extract of <italic>D. tertiolecta</italic> presented a high stimulation of TNF, surpassing LSA, and a low synthesis of IL-10, lower than LSA, mainly at the highest concentrations tested. The diverging results presented in this study from those found in the literature may be due to the difference in the molecules: the extracts investigated in our study were protein-based, whereas those in the studies by Caroprese et&#xa0;al. (<xref ref-type="bibr" rid="B40">40</xref>) and Ciliberti et&#xa0;al. (<xref ref-type="bibr" rid="B41">41</xref>) were from phytosterol isolates.</p>
<p>The cytokines produced by the Th1 profile were directly related to the production of the leishmanicidal factor, which was found in our study, stimulating the synthesis of IFN-&#x3b3; and TNF, in addition to the production of NO. These results also corroborated the data found in the analysis of gene expression of transcriptional factors, which showed the <italic>Tbx21</italic> gene to be a little more expressed than <italic>GATA3</italic> or <italic>FOXP3</italic>, depending on the concentration used.</p>
<p>The strong correlations (positive or negative) found by the stimulation with the extracts, both for cytokines and transcription factor genes, are interesting. Although not significant, a strong negative correlation found between TNF and IL-10 for the extract of <italic>D. tertiolecta</italic> stimulus was observed in the graphs and corroborated with the hypothesis that IL-10 production is dose-dependent. For <italic>A. platensis</italic>, we also observed very strong negative correlations, although not significant, between TNF and Th2 profile cytokines, suggesting an immunomodulatory potential. The very strong positive correlation between the TNF and IL-4 cytokines is also noteworthy, since the increase of a Th1 profile cytokine together with anti-inflammatory cytokines can combat the parasite, as the balance between both profiles (but predominantly Th1) is important to achieve disease control (<xref ref-type="bibr" rid="B42">42</xref>).</p>
<p>Regarding the correlation between genes stimulated by the <italic>A. platensis</italic> extract, the significant positive correlation found between <italic>Tbx21</italic> and <italic>RORc</italic>, transcriptional factors responsible for inducing Th1 and Th17 profiles, respectively, demonstrated the potential to stimulate pro-inflammatory cytokines, a significant aspect of the immune response against the VL parasite.</p>
<p>Finally, when comparing the results of the extracts with those of the reference drugs, we observed that MTF had a selectivity of more than 100 times for the parasite than for the cells of human and canine hosts, showing greater selectivity among all stimuli. On the other hand, Sb<sup>V</sup> had the lowest SI value, demonstrating that all therapeutic candidates were more selective than Sb<sup>V</sup>. Furthermore, an immunological susceptibility profile was observed, unlike the extracts, demonstrating the induction of a protective profile.</p>
<p>In conclusion, these data suggest and demonstrate that the extracts of PMs are promising therapeutic candidates to treat visceral leishmaniasis, with a protective response elicited in the human cells. These extracts will be further evaluated in relation to their ability i) to stimulate parasitological cure in <italic>in-vivo</italic> assays (preclinical trials), ii) to induce an immune response, and iii) to reduce the parasite load, and their action on amastigotes will also be analyzed.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by Aggeu Magalh&#xe3;es Institute - Fiocruz Pernambuco. The patients/participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author Contributions</title>
<p>VV-A planned and performed the experiments, analyzed the data, and wrote the manuscript. JS, IR, and MM helped in carrying out the experiments. JS and AA were responsible for the cultivation of the photosynthetic microorganisms and obtaining the extracts. PA collaborated with referral drugs. RB, DM, and SS wrote sections of the manuscript. RS, VL, and MP contributed substantially to the data analysis and assisted in the writing of the manuscript. All authors contributed to the review of the manuscript and read and approved the submitted version.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This study was partially financed by the Coordination for the Improvement of Higher Education Personnel &#x2013; Brazil (CAPES) (Finance Code 001), the Research Excellence Program (CNPq/PROEP/FIOCRUZ) (400711/2019-2), the National Council for Scientific and Technological Development (CNPq) (PQ 301223/2018.1), and the Foundation for Science and Technology Pernambuco (FACEPE) (Finance Code PBPG &#x2013; 13666-2.11/18).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We would like to thank Dr. Maria Edileusa Felinto de Brito, coordinator of the Leishmaniasis Reference Services at Fiocruz-PE, for supplying the <italic>Leishmania infantum</italic> strain.</p>
</ack>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2022.891495/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2022.891495/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ponte-Sucre</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gamarro</surname> <given-names>F</given-names>
</name>
<name>
<surname>Dujardin</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Barrett</surname> <given-names>MP</given-names>
</name>
<name>
<surname>L&#xf3;pez-V&#xe9;lez</surname> <given-names>R</given-names>
</name>
<name>
<surname>Garc&#xed;a-Hern&#xe1;ndez</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Drug Resistance and Treatment Failure in Leishmaniasis: A 21st Century Challenge</article-title>. <source>PLoS Negl Trop Dis</source> (<year>2017</year>) <volume>11</volume>(<issue>12</issue>):<fpage>1</fpage>&#x2013;<lpage>24</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0006052</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Proverbio</surname> <given-names>D</given-names>
</name>
<name>
<surname>Spada</surname> <given-names>E</given-names>
</name>
<name>
<surname>Bagnagatti-De-Giorgi</surname> <given-names>G</given-names>
</name>
<name>
<surname>Perego</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Failure of Miltefosine Treatment in Two Dogs With Natural <italic>Leishmania Infantum</italic> Infection</article-title>. <source>Case Rep Vet Med</source> (<year>2014</year>) <volume>2014</volume>:<fpage>1</fpage>&#x2013;<lpage>6</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2014/640151</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sukuraman</surname> <given-names>B</given-names>
</name>
<name>
<surname>Madhubala</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Leishmaniasis: Current Status of Vaccine Development</article-title>. <source>Curr Mol Med</source> (<year>2004</year>) <volume>4</volume>:<page-range>667&#x2013;79</page-range>. doi: <pub-id pub-id-type="doi">10.2174/1566524043360203</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexander</surname> <given-names>J</given-names>
</name>
<name>
<surname>Brombacher</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Thelper1/Thelper2 Cells and Resistance/ Susceptibility to <italic>Leishmania</italic> Infection: Is This Paradigm Still Relevant</article-title>? <source>Front Immunol</source> (<year>2012</year>) <volume>3</volume>:<elocation-id>80</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2012.00080</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhowmick</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ravindran</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ali</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>IL-4 Contributes to Failure, and Colludes With IL-10 to Exacerbate Leishmania Donovani Infection Following Administration of a Subcutaneous Leishmanial Antigen Vaccine</article-title>. <source>BMC Microbiol</source> (<year>2014</year>) <volume>14</volume>(<issue>1</issue>):<fpage>8</fpage>&#x2013;<lpage>20</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2180-14-8</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreno</surname> <given-names>J</given-names>
</name>
<name>
<surname>Vouldoukis</surname> <given-names>L</given-names>
</name>
<name>
<surname>Schreiber</surname> <given-names>P</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>V</given-names>
</name>
<name>
<surname>McGahie</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gueguen</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Primary Vaccination With the LiESP/QA-21 Vaccine (CaniLeish&#xae;) Produces a Cell-Mediated Immune Response Which is Still Present 1 Year Later</article-title>. <source>Vet Immunol Immunopathol</source> (<year>2014</year>) <volume>158</volume>(<issue>3-4</issue>):<fpage>199</fpage>&#x2013;<lpage>207</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetimm.2014.01.011</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Resende</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Roatt</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Aguiar-Soares</surname> <given-names>RDO</given-names>
</name>
<name>
<surname>Viana</surname> <given-names>KF</given-names>
</name>
<name>
<surname>Mendon&#xe7;a</surname> <given-names>LZ</given-names>
</name>
<name>
<surname>Lanna</surname> <given-names>MF</given-names>
</name>
<etal/>
</person-group>. <article-title>Cytokine and Nitric Oxide Patterns in Dogs Immunized Withlbsap Vaccine, Before and After Experimental Challenge With Leishmania Chagasi Plus Saliva of <italic>Lutzomyia Longipalpis</italic>
</article-title>. <source>Vet Parasitol</source> (<year>2013</year>) <volume>198</volume>(<issue>3-4</issue>):<page-range>371&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetpar.2013.09.011</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nyl&#xe9;n</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gautam</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Immunological Perspectives of Leishmaniasis</article-title>. <source>J Global Infect Dis</source> (<year>2010</year>) <volume>2</volume>(<issue>2</issue>):<page-range>135&#x2013;46</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/0974-777X.62876</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paul</surname> <given-names>WE</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yamane</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Differentiation of Effector CD4 T Cell Populations</article-title>. <source>Annu Rev  Immunol</source> (<year>2010</year>) <volume>28</volume>(<issue>1</issue>):<page-range>445&#x2013;89</page-range>. doi: <pub-id pub-id-type="doi">10.1146/annurev-immunol-030409-101212</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa-Pereira</surname> <given-names>C</given-names>
</name>
<name>
<surname>Moreira</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Soares</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Marteleto</surname> <given-names>BH</given-names>
</name>
<name>
<surname>Ribeiro</surname> <given-names>VM</given-names>
</name>
<name>
<surname>Fran&#xe7;a-Dias</surname> <given-names>MH</given-names>
</name>
<etal/>
</person-group>. <article-title>One-Year Timeline Kinetics of Cytokine-Mediated Cellular Immunity in Dogs Vaccinated Against Visceral Leishmaniasis</article-title>. <source>BioMed Cent Vet Res</source> (<year>2015</year>) <volume>11</volume>(<issue>1</issue>):<fpage>92</fpage>&#x2013;<lpage>102</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12917-015-0397-6</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shahbazi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zahedifard</surname> <given-names>F</given-names>
</name>
<name>
<surname>Saljoughian</surname> <given-names>N</given-names>
</name>
<name>
<surname>Doroud</surname> <given-names>D</given-names>
</name>
<name>
<surname>Jamshidi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mahdavi</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunological Comparison of DNA Vaccination Using Two Delivery Systems Against Canine Leishmaniasis</article-title>. <source>Vet Parasitol</source> (<year>2015</year>) <volume>212</volume>:<page-range>130&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetpar.2015.07.005</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solano-Gallego</surname> <given-names>L</given-names>
</name>
<name>
<surname>Montserrat-Sangra</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ordeix</surname> <given-names>L</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Orellana</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>
<italic>Leishmania Infantum-</italic>Specific Production of IFN-&#x3b3; and IL-10 in Stimulated Blood From Dogs With Clinical Leishmaniosis</article-title>. <source>Parasites Vectors</source> (<year>2016</year>) <volume>9</volume>:<page-range>317&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13071-016-1598-y</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Amaro</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Guedes</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Malcata</surname> <given-names>FX</given-names>
</name>
</person-group>. <article-title>Antimicrobial Activities of Microalgae: An Invited Review</article-title>. In: <source>In Science Against Microbial Pathogens: Communicating Current Research and Technological Advances; Formatex Research Center</source> <publisher-loc>vol. 3. Badajoz, Spain</publisher-loc> (<year>2011</year>). p. <page-range>1272&#x2013;84</page-range>.</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gamal</surname> <given-names>AAEL</given-names>
</name>
</person-group>. <article-title>Biological Importance of Marine Algae</article-title>. <source>Saudi Pharm J</source> (<year>2010</year>) <volume>18</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>25</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jsps.2009.12.001</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamthe</surname> <given-names>LT</given-names>
</name>
<name>
<surname>Appiah-Opong</surname> <given-names>R</given-names>
</name>
<name>
<surname>Fokou</surname> <given-names>PT</given-names>
</name>
<name>
<surname>Tsabang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Boyom</surname> <given-names>FF</given-names>
</name>
<name>
<surname>Nyarko</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Marine Algae as Source of Novel Antileishmanial Drugs: A Review</article-title>. <source>Mar Drugs</source> (<year>2017</year>) <volume>15</volume>(<issue>11</issue>):<page-range>323&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/md15110323</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lauritano</surname> <given-names>C</given-names>
</name>
<name>
<surname>Andersen</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Hansen</surname> <given-names>E</given-names>
</name>
<name>
<surname>Albrigtsen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Escalera</surname> <given-names>L</given-names>
</name>
<name>
<surname>Esposito</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Bioactivity Screening of Microalgae for Antioxidant, Anti-Inflammatory, Anticancer, Anti-Diabetes, and Antibacterial Activities</article-title>. <source>Front  Mar Sci</source> (<year>2016</year>) <volume>3</volume>:<elocation-id>68</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmars.2016.00068</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname> <given-names>H</given-names>
</name>
<name>
<surname>Cust&#xf3;dio</surname> <given-names>L</given-names>
</name>
<name>
<surname>Rodrigues</surname> <given-names>M</given-names>
</name>
<name>
<surname>De Sousa</surname> <given-names>C</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>M</given-names>
</name>
<name>
<surname>Barreira</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Biological Activities and Chemical Composition of Methanolic Extracts of Selected Autochthonous Microalgae Strains From the Red Sea</article-title>. <source>Mar Drugs</source> (<year>2015</year>) <volume>13</volume>(<issue>6</issue>):<page-range>3531&#x2013;49</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/md13063531</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwak</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Baek</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Woo</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Han</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>BG</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>OY</given-names>
</name>
<etal/>
</person-group>. <article-title>Beneficial Immunostimulatory Effect of Short-Term Chlorellasupplementation: Enhancement of Natural Killer Cell Activity and Early Inflammatory Response (Randomized, Double-Blinded, Placebo-Controlled Trial)</article-title>. <source>Nutr J</source> (<year>2012</year>) <volume>11</volume>:<fpage>53</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1475-2891-11-53</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schlosser</surname> <given-names>UG</given-names>
</name>
</person-group>. <article-title>Sammlung Von Algenkulturen</article-title>. <source>Ber Dtsch Bot Ges</source> (<year>1982</year>) <volume>95</volume>:<fpage>181</fpage>&#x2013;<lpage>276</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1438-8677.1982.tb02862.x</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Guillard</surname> <given-names>RRL</given-names>
</name>
</person-group>. <source>Culture of Phytoplankton for Feeding Marine Invertebrates</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Plenum Press</publisher-name> (<year>1975</year>) p. <fpage>26</fpage>&#x2013;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-4615-8714-9_3</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barros</surname> <given-names>PDS</given-names>
</name>
<name>
<surname>Costa-e-Silva</surname> <given-names>PE</given-names>
</name>
<name>
<surname>Nascimento</surname> <given-names>TP</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>RMPB</given-names>
</name>
<name>
<surname>Bezerra</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Porto</surname> <given-names>ALF</given-names>
</name>
</person-group>. <article-title>Fibrinolytic Enzyme From <italic>Arthrospira Platensis</italic> Cultivated in Medium Culture Supplemented With Corn Steep Liquor</article-title>. <source>Int J Biol Macromol</source> (<year>2020</year>) <volume>164</volume>:<page-range>3446&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijbiomac.2020.08.217</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva-J&#xfa;nior</surname> <given-names>JN</given-names>
</name>
<name>
<surname>Aguiar</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Mota</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Bezerra</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Porto</surname> <given-names>ALF</given-names>
</name>
<name>
<surname>Herculano</surname> <given-names>PN</given-names>
</name>
<etal/>
</person-group>. <article-title>Antimicrobial Activity of Photosynthetic Microorganisms Biomass Extract Against Bacterial Isolates Causing Mastitis</article-title>. <source>Dayri Vet Sci</source> (<year>2019</year>) <volume>10</volume>(<issue>3</issue>):<fpage>1</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.19080/JDVS.2019.10.555788</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname> <given-names>PK</given-names>
</name>
<name>
<surname>Krohn</surname> <given-names>RI</given-names>
</name>
<name>
<surname>Hermanson</surname> <given-names>GT</given-names>
</name>
<name>
<surname>Mallia</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Gartner</surname> <given-names>FH</given-names>
</name>
<name>
<surname>Provenzano</surname> <given-names>MD</given-names>
</name>
<etal/>
</person-group>. <article-title>Measurement of Protein Using Bicinchoninic</article-title>. <source>Acid Anal Biochem</source> (<year>1985</year>) <volume>150</volume>:<fpage>76</fpage>&#x2013;<lpage>85</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0003-2697(85)90442-7</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bradford</surname> <given-names>MM</given-names>
</name>
</person-group>. <article-title>A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding</article-title>. <source>Anal Biochem</source> (<year>1976</year>) <volume>72</volume>:<page-range>248&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/abio.1976.9999</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basak</surname> <given-names>P</given-names>
</name>
<name>
<surname>Paul</surname> <given-names>S</given-names>
</name>
<name>
<surname>Majumder</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>
<italic>In Vitro</italic> Cytotoxic Study of Aloe Vera Whole Leaf Extract on PBMC and Breast Cancer Cell Line</article-title>. <conf-name>2nd International Conference for Convergence in Technology (i2ct)</conf-name> (<year>2017</year>), <page-range>124&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1109/I2CT.2017.8226106</pub-id>.</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Correia</surname> <given-names>VCS</given-names>
</name>
<name>
<surname>Lima</surname> <given-names>NO</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>FAZ</given-names>
</name>
<name>
<surname>Santos</surname> <given-names>APA</given-names>
</name>
<name>
<surname>Teles</surname> <given-names>CBG</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Evaluation of the Antiplasmodial and Leishmanicidal Potential of <italic>Myrciaria Dubia</italic> (Myrtaceae) Extract</article-title>. <source>Rev  Soc Bras Med Trop</source> (<year>2016</year>) <volume>49</volume>(<issue>5</issue>):<page-range>586&#x2013;92</page-range>. doi: <pub-id pub-id-type="doi">10.1590/0037-8682-0227-2016</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mosmann</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays: Application to Proliferation and Cytotoxicity Assays</article-title>. <source>J Immunol Methods</source> (<year>1983</year>) <volume>65</volume>(<issue>1-2</issue>):<fpage>55</fpage>&#x2013;<lpage>63</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0022-1759(83)90303-4</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khademvatan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Eskandari</surname> <given-names>A</given-names>
</name>
<name>
<surname>Saki</surname> <given-names>J</given-names>
</name>
<name>
<surname>Foroutan-Rad</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Cytotoxic Activity of <italic>Holothuria Leucospilota</italic> Extract Against Leishmania Infantum In Vitro</article-title>. <source>Adv Pharmacol Sci</source> (<year>2016</year>) <volume>2016</volume>:<fpage>1</fpage>&#x2013;<lpage>6</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2016/8195381</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comandolli-Wyrepkowski</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Jensen</surname> <given-names>BB</given-names>
</name>
<name>
<surname>Grafova</surname> <given-names>I</given-names>
</name>
<name>
<surname>Santos</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Barros</surname> <given-names>AMC</given-names>
</name>
<name>
<surname>Soares</surname> <given-names>FV</given-names>
</name>
<etal/>
</person-group>. <article-title>Antileishmanial Activity of Extracts From <italic>Libidibia Ferrea</italic>: Development of In Vitro and <italic>In Vivo</italic> Tests</article-title>. <source>Acta Amazonica</source> (<year>2017</year>) <volume>47</volume>(<issue>4</issue>):<page-range>331&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/1809-4392201700871</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morais-Teixeira</surname> <given-names>E</given-names>
</name>
<name>
<surname>Carvalho</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Costa</surname> <given-names>JCS</given-names>
</name>
<name>
<surname>Duarte</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Mendon&#xe7;a</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Boechat</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>
<italic>In Vitro</italic> and <italic>In Vivo</italic> Activity of Meglumine Antimoniate Produced at Farmanguinhos-Fiocruz, Brazil, Against <italic>Leishmania (Leishmania) Amazonensis</italic>, L (L.) Chagasi and <italic>L (Viannia) Braziliensis</italic>
</article-title>. <source>Mem  Inst Oswaldo Cruz</source> (<year>2008</year>) <volume>103</volume>(<issue>4</issue>):<page-range>358&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/s0074-02762008000400008</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morais-Teixeira</surname> <given-names>E</given-names>
</name>
<name>
<surname>Damasceno</surname> <given-names>QS</given-names>
</name>
<name>
<surname>Galuppo</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Romanha</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Rabello</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>The <italic>In Vitro</italic> Leishmanicidal Activity of Hexadecylphosphocholine (Miltefosine) Against Four Medically Relevant <italic>Leishmania</italic> Species of Brazil</article-title>. <source>Mem  Inst Oswaldo Cruz</source> (<year>2011</year>) <volume>106</volume>(<issue>4</issue>):<page-range>475&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1590/S0074-02762011000400015</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pessoa-E-Silva</surname> <given-names>R</given-names>
</name>
<name>
<surname>Trajano-Silva</surname> <given-names>LAM</given-names>
</name>
<name>
<surname>Vaitkevicius-Ant&#xe3;o</surname> <given-names>V</given-names>
</name>
<name>
<surname>Santos</surname> <given-names>WJT</given-names>
</name>
<name>
<surname>Magalh&#xe3;es</surname> <given-names>FB</given-names>
</name>
<name>
<surname>Moura</surname> <given-names>DMN</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunoprophylactic Potential of a New Recombinant <italic>Leishmania Infantum</italic> Antigen for Canine Visceral Leishmaniasis: An <italic>In Vitro</italic> Finding</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>11</volume>:<elocation-id>605044</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.605044</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhargava</surname> <given-names>P</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Developments in Diagnosis and Antileishmanial Drugs</article-title>. <source>Interdiscip Perspect Infect Dis</source> (<year>2012</year>) <volume>2012</volume>:<fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2012/626838</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouyahya</surname> <given-names>A</given-names>
</name>
<name>
<surname>Et-Touys</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bakka</surname> <given-names>N</given-names>
</name>
<name>
<surname>Fellah</surname> <given-names>H</given-names>
</name>
<name>
<surname>Abrini</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bakri</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Antileishmanial Potential of Medicinal Plant Extracts From the North-West of Morocco</article-title>. <source>Beni-Suef Univ J  Basic And Appl Sci</source> (<year>2018</year>) <volume>7</volume>(<issue>1</issue>):<page-range>50&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bjbas.2017.06.003</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sousa</surname> <given-names>CB</given-names>
</name>
<name>
<surname>Gangadhar</surname> <given-names>KN</given-names>
</name>
<name>
<surname>Morais</surname> <given-names>TR</given-names>
</name>
<name>
<surname>Conserva</surname> <given-names>GAA</given-names>
</name>
<name>
<surname>Vizetto-Duarte</surname> <given-names>C</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Antileishmanial Activity of Meroditerpenoids From the Macroalgae Cystoseira Baccata</article-title>. <source>Exp Parasitol</source> (<year>2017</year>) <volume>174</volume>:<fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.exppara.2017.01.002</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa-Silva</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Conserva</surname> <given-names>GAA</given-names>
</name>
<name>
<surname>Galisteo</surname> <given-names>AJ</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Tempone</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Lago</surname> <given-names>JHG</given-names>
</name>
</person-group>. <article-title>Antileishmanial Activity and Immunomodulatory Effect of Secosubamolide, a Butanolide Isolated From <italic>Nectandra Oppositifolia</italic> (Lauraceae)</article-title>. <source>J  Venom Anim And Toxins Incl Trop Dis</source> (<year>2019</year>) <volume>25</volume>:<fpage>1</fpage>&#x2013;<lpage>8</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/1678-9199-jvatitd-2019-0008</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shokri</surname> <given-names>H</given-names>
</name>
<name>
<surname>Khosravi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Taghavi</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Efficacy of Spirulina Platensis on Immune Functions in Cancer Mice With Systemic Candidiasis</article-title>. <source>J Mycol Res</source> (<year>2014</year>) <volume>1</volume>(<issue>1</issue>):<fpage>7</fpage>&#x2013;<lpage>13</lpage>.</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname> <given-names>TK</given-names>
</name>
<name>
<surname>Water</surname> <given-names>JV</given-names>
</name>
<name>
<surname>Gershwin</surname> <given-names>ME</given-names>
</name>
</person-group>. <article-title>Effect of <italic>Spirulina</italic> on the Secretion of Cytokines From Peripheral Blood Mononuclear Cells</article-title>. <source>J Med Food</source> (<year>2000</year>) <volume>3</volume>(<issue>3</issue>):<page-range>135&#x2013;40</page-range>. doi: <pub-id pub-id-type="doi">10.1089/jmf.2000.3.135</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheikh</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Shalaby</surname> <given-names>MAM</given-names>
</name>
<name>
<surname>Hafez</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Metwally</surname> <given-names>WSA</given-names>
</name>
<name>
<surname>El-Ayoty</surname> <given-names>YM</given-names>
</name>
</person-group>. <article-title>The Immunomodulatory Effects of Probiotic Bacteria on Peripheral Blood Mononuclear Cells (PBMCs) of Allergic Patients</article-title>. <source>Am J Immunol</source> (<year>2014</year>) <volume>10</volume>(<issue>3</issue>):<page-range>116&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3844/ajisp.2014.116.130</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciliberti</surname> <given-names>M</given-names>
</name>
<name>
<surname>Francavilla</surname> <given-names>M</given-names>
</name>
<name>
<surname>Intini</surname> <given-names>S</given-names>
</name>
<name>
<surname>Albenzio</surname> <given-names>M</given-names>
</name>
<name>
<surname>Marino</surname> <given-names>R</given-names>
</name>
<name>
<surname>Santillo</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Phytosterols From Dunaliella Tertiolecta Reduce Cell Proliferation in Sheep Fed Flaxseed During Post Partum</article-title>. <source>Mar Drugs</source> (<year>2017</year>) <volume>15</volume>(<issue>7</issue>):<page-range>216&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/md15070216</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caroprese</surname> <given-names>M</given-names>
</name>
<name>
<surname>Albenzio</surname> <given-names>MGC</given-names>
</name>
<name>
<surname>Matteo</surname> <given-names>F</given-names>
</name>
<name>
<surname>Agostino</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>A Mixture of Phytosterols From <italic>Dunaliella Tertiolecta</italic> Affects Proliferation of Peripheral Blood Mononuclear Cells and Cytokine Production in Sheep</article-title>. <source>Vet Immunol And Immunopathol</source> (<year>2012</year>) <volume>150</volume>(<issue>1</issue>):<fpage>27</fpage>&#x2013;<lpage>35</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetimm.2012.08.002</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez-Cort&#xe9;z</surname> <given-names>A</given-names>
</name>
<name>
<surname>Carrillo</surname> <given-names>E</given-names>
</name>
<name>
<surname>Martorell</surname> <given-names>S</given-names>
</name>
<name>
<surname>Todol&#xed;</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ojeda</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Fl&#xf3;rez</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Compartmentalized Immune Response in Leishmaniasis: Changing Patterns Throughout the Disease</article-title>. <source>PLoS One</source> (<year>2016</year>) <volume>11</volume>(<issue>5</issue>):<fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0155224</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>